Japan Approves World’s First ‘Self-Amplifying’ mRNA COVID-19 Vaccine Without Published Efficacy or Safety Data

Contact Your Elected Officials
The Epoch Times Header

The latest iteration of the mRNA vaccine is even more potent than the present version, as it generates more spike proteins in the human body.

Japan has approved the world’s first self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, although the manufacturer has not published safety or efficacy data for the shot.

Tokyo-based Meiji Seika Pharma received approval for manufacturing and marketing its Kostaive sa-mRNA COVID-19 vaccine, the company announced in a Nov. 28 press release. The mRNA in the vaccine is designed to self-amplify when delivered into cells, which generates a “strong immune response and the potential for extended duration of protection.” The vaccine is intended for primary immunization (2 doses) as well as booster immunization in adults. Kostaive is the “world’s first approved product applying self-amplifying mRNA technology,” according to the press release.

Both mRNA and sa-mRNA are RNA vaccines that use a virus’ genetic code against it. When an mRNA vaccine is injected into an individual, the mRNA instructs cells to make a specific protein and thus stimulates immune response. An sa-mRNA vaccine takes this concept further by making multiple mRNA copies, which ends up generating more spike protein.

Toby Young, general secretary of the Free Speech Union, a public interest group, pointed out in a Nov. 30 X post that the sa-mRNA vaccine was approved in Japan “despite only testing it on 800 people, no control group and only checking antibody levels not infection rates. Medicine regulation died with Covid.”

A phase 3 study compared the Kostaive ARCT-154 vaccine to Pfizer’s Comirnaty mRNA COVID-19 vaccine. The pre-print study, which has not been peer-reviewed, was posted in July at MedRxiv.

The study, funded by the Japanese Ministry of Health, Labour and Welfare, followed a primary phase study that analyzed the safety and efficacy of the Kostaive vaccine. The results of that study have not been published; the manuscript is “in preparation,” according to the phase 3 study report.

The trial was conducted among 828 people between December 2022 and February 2023. This is a far lower number of participants than Pfizer’s phase 3 study, which involved over 40,000 individuals. The small scale of Kostaive trial has raised questions about its validity.

By Naveen Athrappully

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Five Reasons Why The Latest Czech Elections Were So Important

Populist-nationalist politician Andrej Babis is poised to return to the premiership after his party's victory. Here are 5 reasons why this is so important.

Bad Bunny is the NFL’s Latest Insult

After years of advocating social justice causes, the NFL chose left wing, gender fluid rapper Bad Bunny to headline the next Super Bowl. Does the NFL want conservatives fans?

Scheduling collides with legacy

The ACC’s footprint now sprawls from Boston and Miami to Salt Lake City and the San Francisco Bay, defying both geography and its own name.

The Paradoxical Patriot: The political odyssey of Frank S. Meyer

In his book, Daniel J. Flynn examines the ideological evolution of one of conservatism’s most paradoxical and overlooked architects, Frank S. Meyer. 

This Is America: Target™ Reparations

“This Is America” explores the cultural undercurrents pulling Western...

Judge Upholds Nassau County Ban on Transgender Athletes in Women’s Sports

A New York judge on Oct. 6 upheld a Long Island county law banning male athletes from participating in women’s sports at county-run facilities.

FBI Surveilled 8 GOP Members of Congress, Document Shows

The FBI surveilled Republican senators as part of its Arctic Frost investigation, a newly disclosed document shows.

Acting CDC Director Calls on Manufacturers to Break MMR Vaccine Into Separate Shots

A commonly used combination vaccine against measles should be replaced with separate shots, the acting director of the CDC said on Oct. 6.

Trump Says He May Invoke Insurrection Act in Portland If Necessary

President Donald Trump on Oct. 6 said he may consider invoking the Insurrection Act in Portland, Oregon, if necessary.

Trump Says He May Invoke Insurrection Act in Portland If Necessary

President Donald Trump on Oct. 6 said he may consider invoking the Insurrection Act in Portland, Oregon, if necessary.

Trump: All Medium, Heavy Duty Trucks Entering US Will See 25 Percent Tariff on Nov. 1

President Trump announced on Monday that all medium and heavy-duty trucks entering the United States will see a 25 percent tariff starting on Nov. 1.

Treasury Names Social Security Commissioner as CEO of IRS

Treasury Sec. Scott Bessent announced that Frank Bisignano, the head of the Social Security Administration (SSA), will also serve as CEO of the IRS.

Agencies Terminated, Descoped 94 Wasteful Contracts With $8.5 Billion Ceiling Value, Says DOGE

Various federal government agencies have terminated and descoped 94 wasteful contracts over the past five days, DOGE said in an Oct. 4 post on X.
spot_img

Related Articles

Popular Categories

MAGA Business Central